Ray Co., Ltd. (KOSDAQ:228670)
8,430.00
+180.00 (2.18%)
Jun 5, 2025, 3:30 PM KST
Ray Co., Ltd. Revenue
Ray Co., Ltd. had revenue of 24.46B KRW in the quarter ending March 31, 2025, with 40.86% growth. This brings the company's revenue in the last twelve months to 86.94B, down -39.30% year-over-year. In the year 2024, Ray Co., Ltd. had annual revenue of 79.84B, down -45.27%.
Revenue (ttm)
86.94B
Revenue Growth
-39.30%
P/S Ratio
1.47
Revenue / Employee
493.97M
Employees
176
Market Cap
127.98B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 79.84B | -66.04B | -45.27% |
Dec 31, 2023 | 145.88B | 16.88B | 13.09% |
Dec 31, 2022 | 129.00B | 38.66B | 42.80% |
Dec 31, 2021 | 90.34B | 35.13B | 63.64% |
Dec 31, 2020 | 55.20B | -17.90B | -24.49% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |